Alps Group Inc
Alps Group Inc (ALPS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALPS · as of Jun 9, 2026
Key Statistics
Explore Alps Group Inc Data
alps stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
alps competitorsALPS
ARGYF
BNRG
CHKR
EDBL
GIPRStock Performance
Full HistoryAbout Alps Group Inc
Alps Group Inc operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization …
what is alps group inc · alps stock overview · alps group inc company profile · who is alps group inc ceo · alps NASDAQ · alps group inc headquarters · alps group inc business segments
About Stock Overview & Key Data
Alps Group Inc (ALPS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 31, 2025. As of the latest trading session, ALPS stock price is $0.72, with a market capitalization of $119.4M. The stock has returned -94.03% over the past 12 months and -17.47% year-to-date.
In fiscal year 2025, Alps Group Inc reported revenue of $3.4M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Alps Group Inc (ALPS) stock price is $0.72. The stock is traded on NASDAQ under the ticker symbol ALPS. The 52-week range is $0.56 – $2.90.